Show simple item record

dc.identifier.urihttp://hdl.handle.net/11401/77080
dc.description.sponsorshipThis work is sponsored by the Stony Brook University Graduate School in compliance with the requirements for completion of degree.en_US
dc.formatMonograph
dc.format.mediumElectronic Resourceen_US
dc.language.isoen_US
dc.publisherThe Graduate School, Stony Brook University: Stony Brook, NY.
dc.typeThesis
dcterms.abstractIslet amyloid polypeptide (IAPP) is a 37 residues long polypeptide hormone. IAPP is co-secreted with insulin by the B-cells in the pancreas and is stored with insulin in secretory vesicles. IAPP helps to maintain glucose homeostasis in the body by regulating glucagon secretion. IAPP is one of the most amyloidogenic peptide known, and IAPP amyloid formation plays a role in type 2 diabetes. IAPP amyloid formation contributes to B-cells dysfunction and B-cells loss in islets. There is one known naturally found IAPP mutant; the serine 20 to glycine (S20G) mutant weakly increases the risk of early onset diabetes in Asian populations. In vitro studies provided the evidence that the S20G mutant accelerates amyloid formation. This thesis research is about the molecular mechanism of accelerating amyloid formation by the S20G mutant. Studies with D-amino acid mutants at position 20 confirm that increased rate of amyloid formation by S20G mutant is not the result as of unusual backbone conformation adopted by serine 20 in the wild type peptide. Experiments using helical prone natural and unnatural amino acid substitution show that enhanced amyloid formation by the S20G mutant is not the result of a steric clash or the relief of unfavorable hydrogen bond interactions that slow amyloid formation in wild type IAPP. Analysis of a S19G mutant confirms the specific amyloidogenic profile of the S20G mutant. Seeding studies suggests that the single point mutations do not cause significant changes in final fibril structure.
dcterms.available2017-09-20T16:51:54Z
dcterms.contributorCarrico, Isaacen_US
dcterms.contributorRaleigh, Daniel Pen_US
dcterms.contributorMiller, Lisa.en_US
dcterms.creatorAkter, Rehana
dcterms.dateAccepted2017-09-20T16:51:54Z
dcterms.dateSubmitted2017-09-20T16:51:54Z
dcterms.descriptionDepartment of Chemistry.en_US
dcterms.extent103 pg.en_US
dcterms.formatApplication/PDFen_US
dcterms.formatMonograph
dcterms.identifierhttp://hdl.handle.net/11401/77080
dcterms.issued2013-12-01
dcterms.languageen_US
dcterms.provenanceMade available in DSpace on 2017-09-20T16:51:54Z (GMT). No. of bitstreams: 1 Akter_grad.sunysb_0771M_11672.pdf: 5305558 bytes, checksum: 26166c7561dc05452fa08ad5291aae1b (MD5) Previous issue date: 1en
dcterms.publisherThe Graduate School, Stony Brook University: Stony Brook, NY.
dcterms.subjectAmylin, Islet amyloid polypeptide, S20G, type 2 diabetes
dcterms.subjectChemistry
dcterms.titleAccelerating Amyloid Formation by Islet Amyloid Polypeptide
dcterms.typeThesis


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record